From network pharmacology to molecular docking analysis of sterubin targets for Alzheimer.

Sterubin (7-O-Methyleriodicytol), a flavanone compound isolated from the leaves of Eriodicyton californicum and Eriodicyton angustifolium, has neuroprotective, anti-inflammatory, and antioxidant properties. Therefore, it is of interest to identify the potential targets for Alzheimer disease using network pharmacology. We report 25 overlapping targets among 100 potential targets of sterubin and 673 known targets of Alzheimer.

Molecular docking analysis of flavonoids with AChE and BACE-1.

Flavonoids are promising therapeutics for the treatment of Alzheimer's disease (AD). Therefore, it is of interest to study the anti-AD potential of 35 flavonoids towards the inhibition of AchE and BACE-1. Hence, the physicochemical, pharmacokinetic parameters, toxicity risk and drug-likeliness of the selected 35 flavonoids were computed.

Insights from molecular network analysis to docking of sterubin with potential targets.

The use of a flavonoid compound sterubin in drug discovery is gaining momentum. Hence, it is of interest to document the molecular network analysis to docking of sterubin with potential targets to glean insights. We identified 32 target genes and (or) gene products for sterubin using DAVID tools for GO, KEGG pathway enrichment analyses and the STRING database.